KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Encompass Health (EHC) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $44.9 million.

  • Encompass Health's Tax Provisions rose 2472.22% to $44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $175.1 million, marking a year-over-year increase of 1688.92%. This contributed to the annual value of $150.2 million for FY2024, which is 1361.57% up from last year.
  • Latest data reveals that Encompass Health reported Tax Provisions of $44.9 million as of Q3 2025, which was up 2472.22% from $51.0 million recorded in Q2 2025.
  • In the past 5 years, Encompass Health's Tax Provisions ranged from a high of $51.0 million in Q2 2025 and a low of $21.8 million during Q3 2022
  • Its 5-year average for Tax Provisions is $32.7 million, with a median of $31.9 million in 2022.
  • The largest annual percentage gain for Encompass Health's Tax Provisions in the last 5 years was 13898.31% (2021), contrasted with its biggest fall of 4078.95% (2021).
  • Over the past 5 years, Encompass Health's Tax Provisions (Quarter) stood at $22.5 million in 2021, then skyrocketed by 41.78% to $31.9 million in 2022, then increased by 16.61% to $37.2 million in 2023, then increased by 1.08% to $37.6 million in 2024, then grew by 19.41% to $44.9 million in 2025.
  • Its Tax Provisions stands at $44.9 million for Q3 2025, versus $51.0 million for Q2 2025 and $41.6 million for Q1 2025.